Back
Palo Alto Networks, Inc. Vs. Nektar Therapeutics Industry Stock Comparison
Sell
46
PANW
Palo Alto Networks, Inc.
Last Price:
$190.37
Seasonality Move:
8.47%
Sell
33
NKTR
Nektar Therapeutics
Last Price:
$51.10
Seasonality Move:
11.58%
Sell
46
Palo Alto Networks, Inc. (PANW)
is a Sell
Is Palo Alto Networks, Inc. a Buy, Sell or Hold?
-
The current Palo Alto Networks, Inc. [PANW] share price is $190.36. The Score for PANW is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
PANW is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $51.12. The Score for NKTR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PANW Stock Price Chart
What is Palo Alto Networks, Inc.'s stock price today?
-
The Palo Alto Networks, Inc. share price today is $190.36Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PANW is experiencing slight selling pressure.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $51.12Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.
PANW Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.55 | Sell |
| Relative Strength Index (14 RSI): | 40.36 | Sell |
| Chaikin Money Flow: | -825157 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (187.1 - 207.72) | Sell |
| Bollinger Bands (100): | (183.56 - 212.02) | Sell |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.55 | Sell |
| Relative Strength Index (14 RSI): | 39.75 | Sell |
| Chaikin Money Flow: | -893008 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.73 - 61.07) | Sell |
| Bollinger Bands (100): | (32.3 - 62.42) | Buy |
PANW Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 193.96 | Sell |
| 20-day SMA: | 193.34 | Sell |
| 50-day SMA: | 205.46 | Sell |
| 200-day SMA: | 192.13 | Sell |
| 8-day EMA: | 193.08 | Sell |
| 20-day EMA: | 195.62 | Sell |
| 50-day EMA: | 199.89 | Sell |
| 200-day EMA: | 193.85 | Sell |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.44 | Sell |
| 20-day SMA: | 58.08 | Sell |
| 50-day SMA: | 58.52 | Sell |
| 200-day SMA: | 30.43 | Buy |
| 8-day EMA: | 56.58 | Sell |
| 20-day EMA: | 57.71 | Sell |
| 50-day EMA: | 55.82 | Sell |
| 200-day EMA: | 37.69 | Buy |
Palo Alto Networks, Inc. Earnings Growth & PANW Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.04 per share, an increase this year of $0.49 per share, and an increase next year of $0.58 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.
Palo Alto Networks, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||